In 2025, Liverscan® continued to appear at multiple professional medical conferences in Egypt. During the conference, local top medical experts and representatives of authoritative medical institutions had a deep understanding and exploration of Liverscan®. Through on-site demonstrations and professional explanations, Liverscan® showed its leading advantages in detection accuracy, convenience, and other aspects, laying a solid foundation for the subsequent development of the African market.
GOTHI
The Annual Scientific Conference of the General Organization for Teaching Hospitals and Institutes
On January 13-14, 2025, the Annual Scientific Conference of The General Organization for Teaching Hospitals and Institutes (GOTHI 2025) was held in Cairo, Egypt. The theme of the conference was “Obesity – a multidimensional perspective from medicine to the community”, focusing on the comprehensive prevention and control of metabolic diseases.
Liverscan®, with its breakthrough detection technology, demonstrated its application value in the early screening and diagnosis of chronic liver disease, and received the attention of local experts and scholars during the conference. Liverscan®, with its non-invasive detection method, greatly reduces the risk for patients. It is easy to operate and can quickly and accurately screen potential patients with hepatic steatosis in the general population, providing a new idea for solving the problem of liver disease screening for obese people in Africa.
NLICC
National Liver Institute Collaboration Conference
From February 13 to 15, 2025, the National Liver Institute Collaboration Conference (NLICC 2025) was held in Cairo, Egypt, focusing on cutting-edge topics such as digestive diseases, hepatobiliary health, and metabolic disorders. As an indispensable tool in the liver disease management process, Liverscan® has won the recognition of on-site professionals and audiences with its accurate and reliable detection performance. Liverscan® can simplify the liver disease diagnosis process and save local medical costs in Africa. It can assist doctors in adopting more targeted treatment methods, improve the level of medical services in Africa, and promote the progress of chronic liver disease management.
Endemic Department Annual Conference
In March 2025, the Faculty of Medicine of Cairo University (the oldest medical school in Egypt) held the Endemic Department Annual Conference, where Liverscan® made a stunning debut as the latest solution for non-invasive liver testing. This academic conference, which brought together top local experts, provided Liverscan® with a valuable opportunity to have in-depth exchanges with authoritative scholars.
On-site experts, scholars, and potential partners gained an in-depth understanding of the product advantages and clinical value of Liverscan® and expressed praise and recognition for Liverscan®’s breakthrough performance in detection accuracy and ease of operation.
EFHM
Egyptian Foundation for Helicobacter and Microbiota
On May 30, 2025, Liverscan® continued to appear at the 2025 Annual Meeting of the Egyptian Foundation for Helicobacter and Microbiota (EFHM 2025), hosted by the authoritative Egyptian Foundation for Helicobacter and Microbiota Foundation. As a leader in elastic imaging wireless ultrasound application equipment in the field of chronic liver disease, Liverscan® has significantly optimized the existing liver disease diagnosis and treatment plans, especially for early liver screening. Its innovative detection methods and reliable detection capabilities have won the attention and favor of many experts, scholars, and on-site customers.
The development of liver disease is hidden, and patients are often not diagnosed until symptoms appear. At this time, the disease has progressed to the middle and late stages, and the best intervention period has been missed. Early screening and early detection can discover potential causes and achieve timely reversal. As a provider of liver health solutions, Eieling Technology is constantly expanding overseas markets and providing accurate testing services to more people to change the current situation of insufficient early screening rates for liver disease. In the future, Eieling Technology will continue to innovate technology so that more patients can benefit from accurate and non-invasive liver health management solutions, helping to achieve the goal of eliminating hepatitis by 2030.